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Accelerated Wound Repair in ADAM-9 Knockout
Animals
Cornelia Mauch1, Jan Zamek1, Anna N. Abety1, Gundula Grimberg1, Jay W. Fox2 and Paola Zigrino1
ADAM-9 belongs to a family of transmembrane, disintegrin-containing metalloproteinases (ADAMs) involved in
protein ectodomain shedding and cell–cell and cell–matrix interactions. Although the functions of many ADAM
family members are known, the specific biological function of ADAM-9 is still unclear. In this study, we have
analyzed ADAM-9 temporal and spatial distribution during wound healing. We showed increased ADAM-9
transcript expression during the first 7 days post-wounding and, by immunolocalization, detected ADAM-9 in all
migrating and proliferating keratinocytes from days 3 to 7. In older 14-day-old wounds, ADAM-9 expression was
restored. We have investigated the role of this protein in the healing process following excisional wounding.
Animals deficient in ADAM-9 showed accelerated wound repair compared with control littermates. No
alterations in neutrophil, leukocyte, and macrophage infiltration were observed. However, re-epithelialization
was significantly faster in Adam-9 / than control wounds. Although no differences in proliferation were
observed in vivo and in vitro, increased migration of keratinocytes was responsible for this effect. These results
show the previously unreported role of ADAM-9 in wound repair by regulating keratinocyte migration through
modulation of collagen XVII shedding.
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INTRODUCTION
The process of wound healing begins the moment the tissue is
injured. After the formation of a clot that seals the wound,
inflammation, re-epithelialization, granulation tissue formation,
and matrix remodeling are required to complete healing by
restoring the structure and function of the tissue. Proteolysis is
required in many of these stages and is directed both to the
degradation of damaged tissue and remodeling of the new
extracellular matrix as well as to the release and activation of
growth factors and cytokines generating signals, which directly
or indirectly promote cell growth and migration (Bergers and
Coussens, 2000; Blobel, 2002). Different families of proteinases
(serine, cysteine, aspartic proteinases, and metalloproteinases)
have been implicated in wound healing during which they
have an important role in cell migration and extracellular
matrix remodeling. In addition to these enzyme families,
ADAM (A Disintegrin And Metalloproteinase) proteases,
initially described as sheddases of cell membrane proteins,
have also been shown to be involved in the degradation of
extracellular matrix proteins (Millichip et al., 1998; Alfandari
et al., 2001; Schwettmann and Tschesche, 2001; Martin et al.,
2002). ADAM-9, -10, and -17 are expressed more in the
epidermis and less in the dermal compartment, and are
involved in the cleavage of collagen XVII as well as of cell
surface receptors, such as E-cadherin, both thereby modulating
cell migration (Franzke et al., 2002; Maretzky et al., 2005). In
addition, ADAM-9 cleaves and releases epidermal growth
factor (EGF), fibroblast growth factor receptor 2 IIIb as well as
heparin-binding EGF-like growth factor from cells (Peduto et al.,
2005), all of which have pivotal functions in wound healing.
Previous studies have shown that activated CD4þT lym-
phocytes and lymphoma cells express ADAM-9 and -17 in vitro
(Wolf et al., 2003). In addition, expression of ADAM-9 has been
detected in circulating monocytes as well as in macrophages
and shown to be involved in the formation of multinuclear giant
cells in both bone and skin (Namba et al., 2001; Mackiewicz
et al., 2005; Ma et al., 2006), thereby implying the putative
involvement of ADAM-9 in inflammatory processes.
Increased expression of ADAM-9 was observed in vivo
during vessel repair following angioplasty (Ward et al., 2001)
as well as during horse skin repair (Lefebvre-Lavoie et al.,
2005). In a recent study, we detected ADAM-9 protein and
transcripts in both the epidermal and dermal compartments
of normal human skin (Zigrino et al., 2007). Furthermore, we
have also shown that ADAM-9 interacts with integrin-b1 on
keratinocytes whose interaction with the adhesive domains of
ADAM-9 leads to the secretion of matrix metalloproteinase
(MMP)-9 and modulation of cell migration (Zigrino et al.,
2007). However, it is still unclear as to the role of ADAM-9 in
skin and during physiological processes such as wound
healing in vivo.
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In this investigation, using mice carrying a complete
inactivation of the Adam-9 gene, we have addressed the role
of ADAM-9 in wound healing processes in vivo. Further, we
showed that wound re-epithelialization in vivo is modulated
by the expression and activity of ADAM-9 in keratinocytes.
Finally, we have shown that the absence of this protease
reduced cleavage of collagen XVII and resulted in increased
migration of keratinocytes in vivo and in vitro.
RESULTS
ADAM-9 expression during normal wound healing and in
human chronic wounds
In a recent study, we could show that ADAM-9 protein and
transcripts are detected in both the epidermal and dermal
compartments. To test whether ADAM-9 expression is
modulated during wound healing, we have generated full-
thickness excisional wounds (4mm Ø) on the backs of C57/
Bl6 control animals. At the indicated time points, the mice
were killed and the wounds processed for histology and
transcript analysis. High ADAM-9 transcript levels were
detected between 6 hours and 6 days post-wounding
compared with unwounded skin and with wounds 7–14 days
after injury (Figure 1a).
ADAM-9 protein was expressed in epidermal keratino-
cytes in unwounded skin. On wounding, its expression was
associated with all migrating and proliferating keratinocytes
from days 3–11 (Figure 1b). On day 14, wound expression of
ADAM-9 was found in all keratinocytes with prominent
expression in suprabasal layers comparable to the expression
pattern observed in non-wounded skin.
To analyze the role of ADAM-9 during wound repair, we
have used ADAM-9 knockout (KO) and wild-type (WT)
animals. Despite Adam-9 deficiency, mice developed nor-
mally, were fertile, showed no gross phenotypic abnorma-
lities, and were indistinguishable from their WT littermates
and controls, being in agreement with published data
(Weskamp et al., 2002).
Histological examination of the back skin of 8-week-old
mice revealed no obvious difference between Adam-9 WT
and KO animals in overall skin morphology (Figure 2h and e).
Likewise, expression analysis of keratin 14, a cytokeratin
protein expressed in the basal keratinocyte layer of the skin,
and loricrin, a protein representative for the stratum
granulosum, indicated normal keratinocyte differentiation in
Adam-9 KO mice (Figure 2).
Cutaneous wound healing in Adam-9 KO mice
To study the physiological role of Adam-9 during wound
healing, we generated full-thickness excisional wounds on
the back skin of 8-week-old Adam-9 KO and WT littermate
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Figure 1. ADAM-9 expression during wound healing and in chronic wounds. (a) Reverse transcription-PCR of ADAM-9 on RNA isolated from wounds of
control animals at different time points. Amplification of S26 was used as control. (b) Shows an overview of the wounds stained for ADAM-9 localization at days
1, 2, 5, 7, and 14 after wounding as well as an unwounded control. The small insert represents the stained Adam-9 knockout (KO) wounds. The arrow marks the
wound margin and the broken line underlines the epithelial tongue. Scale bar, 100mm.
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mice. On injury, wound closure was assessed by histological
analysis of wounds (Figure 3a) and by following the wound
closure kinetics that was expressed as wound area percentage
versus initial area. Measuring the area of the wounds as well
as the distance between the leading wound edges on sections
of Adam-9 KO and WT mice at different time points
after wounding revealed a significant acceleration in wound
closure as early as day 1 post-wounding (Po0.0001;
Figure 3b).
These data show that re-epithelialization after cutaneous
injury is affected by the loss of Adam-9 expression/function,
suggesting that ADAM-9 is required during the initial phases
of wound healing but can be functionally replaced later on by
other ADAMs. Furthermore, an upregulation of ADAM-10
and -17 transcripts at day 3 post-wounding (Figure 3c) was
detected by quantitative and semi-quantitative PCR (Figure
3c, right) and would suggest that these ADAMs may replace
ADAM-9 function to lead to normal skin repair.
Granulation tissue formation at the wound sites
Expression of ADAM-9 in tissues is quite broad and dermal
fibroblasts as well as cells of the immune system express
ADAM-9, activated lymphocytes, peripheral blood mono-
nuclear cells and macrophages (Namba et al., 2001;
Mackiewicz et al., 2005; Ma et al., 2006); however, apart
from the documented activity in cell fusion for the formation
of giant cells, it is unclear whether ADAM-9 expression is
also necessary for efficient inflammatory reaction. To analyze
the inflammatory response to wounding tissue sections from
days 1–5, wounds were analyzed for the infiltration of
macrophages and neutrophils. As shown in Figure 4, infiltra-
tion of neutrophils and macrophages (positive for CD68 and
F4/80) was comparable in wounds of both Adam-9 KO and
WT mice.
Keratinocyte re-epithelialization of wounds
ADAM-9 expression and activity in keratinocytes have
been shown to modulate cell migration by one or more of
the following processes: either cleaving collagen XVII,
inducing expression of MMP-9 in migrating keratinocytes
WT KO
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Figure 2. Analyses of epidermal tissue morphology and differentiation in
ADAM-9 knockout (KO) animals. Overview of the skin stained for
hematoxylin/eosin (H&E). Keratin 14 (K14) and Loricrin were used to
analyze epidermal differentiation and early and late keratinocyte
differentiation, respectively, in wild-type (WT) and Adam-9 / (KO)
animals. Scale bar, 100 mm.
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Figure 3. Accelerated wound closure in knockout (KO) mice. The healing
process of 4mm full-thickness excisional wounds in the back skin of Adam-9
mutant (KO) and control mice (wild-type, WT) were followed over 7 days
(n¼16 per genotype and time point). (a) Photomicrographs and histological
sections indicated accelerated wound healing in Adam-9 KO mice.
Arrowheads indicate wound edges. Scale bar, 200 mm. (b) Closure of wounds
from Adam-9 KO and WT mice at days 2, 5, and 7 (n¼ 4 wounds per
genotype and time point) was judged microscopically and the number of
open wounds was calculated in percent. (c) ADAM-9, -10, and -17 were
amplified by quantitative PCR on RNA isolated from four different animals
(graphs) at days 1,3, and 5 post-wounding. On the right, reverse transcription-
PCR of these transcripts was, in addition, performed on pooled RNA wounds
isolated from four different WT and KO animals. Amplification of S26 was
used as control.
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(Zigrino et al., 2007), and/or modulating the shedding of
heparin-binding EGF-like growth factor (Izumi et al., 1998).
To show a possible function of ADAM-9 in keratinocyte re-
epithelialization in vivo, we performed histological examina-
tion of the wounds at early time points. This analysis revealed
significantly increased length of keratinocyte migratory
tongue over the wound bed of KO compared with WT
animals (Po0.001). These data were obtained by measuring
the length of the migrated tip (marked by the red dotted line)
of the wound at days 3 and 5 post-wounding (Figure 5a).
The observed increase in length of the migrating tip was
not due to increased proliferation as no differences in the
number of Ki67 positive cells, used as proliferation markers,
were observed at the edge (arrow) or into the migrating tip of
both wounds (Figure 5b). These data indicate that the loss of
ADAM-9 leads to increased keratinocyte re-epithelialization
of the wounds.
We had previously shown that the interaction of kerati-
nocytes with the adhesive domains of ADAM-9 leads to the
secretion of MMP-9 and modulation of keratinocyte migra-
tion (Zigrino et al., 2007). MMP-9 expression in wounds at
days 3 and 5 shows a slight reduction in the epithelial tongue
of migrating keratinocytes in Adam-9 KO but not WT animals
(data not shown). However, a difference in the total MMP-9
activity in wound lysates was not observed by gelatin
zymography (data not shown), but the possibility remains
that the difference is below the level of detection. Further-
more, it is unclear at this point whether MMP-9 in vivo
derives from the epithelial cells or the stromal cell.
Analysis of collagen XVII distribution in wounds from WT
and KO animals shows an increased basolateral immunopo-
sitive reaction in the keratinocytes of the migrating tip of the
KO, which was not obvious in WT animals (Figure 6a, white
arrows). This is in agreement with previous studies showing
that shedding of collagen XVII results in decreased keratino-
cyte motility (Franzke et al., 2002). Furthermore, analysis of
tissue lysates from wounds at days 1 and 5 shows the
presence of shed collagen XVII at day 1 post-wounding only
in lysates from WT wounds but not from KO-extracted
wounds (Figure 6b).
In vitro analysis of isolated epidermal keratinocytes
To analyze whether the altered migration of keratinocytes
in vivo results from the alteration of a molecular path in these
cells or in their communication with stromal cells, we have
isolated primary keratinocytes and studied their migratory
potential in vitro by time-lapse video microscopy. After
reaching confluency, keratinocytes were treated with mito-
mycin to block proliferation. ‘‘Wounds’’ were made in the
center of the confluent monolayer of mitotically arrested cells
and cell migration was monitored over 24 hours. Quantifica-
tion of migrated distance in KO and WT keratinocytes shows
increased migration 6 hours post-wounding that was most
significant after 12 hours. This effect is promptly visible in the
phase contrast images shown in Figure 7.
These data show that ADAM-9 ablation in keratinocytes
results in increased cell migration resulting from a keratino-
cyte-dependent effect.
In addition, analysis of supernatants from cultured primary
keratinocytes shows constitutive shed collagen XVII released
in the supernatants of WT but not KO keratinocytes at time 0,
which progressively increased after 6 and 24 hours
(Figure 8a). Shed collagen XVII was detected in supernatants
of KO keratinocytes only after 24 hours. Furthermore,
zymographic analyses of these supernatants show a normal
secretion of MMP-9 and -2 (Figure 8b).
Neutrophils
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Figure 4. Histological analyses of the granulation tissue at wound sites. Localization of macrophages using anti-CD68, as well as F4/80 and neutrophils using
anti-neutrophil antibodies (both in green), showed no obvious differences in the infiltration of these cells in the granulation tissue of both knockout (KO)
and wild-type (WT) animals. Day 5 wounds are shown here. Scale bar, 100 mm.
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Transient transfection of human soluble ADAM-9 (active
or catalytically inactivated by the mutation E4A) in KO
mouse keratinocytes led to the presence of the metallopro-
teinase in the cell culture supernatant (Figure 8c) and the
associated collagen XVII shedding. The inactive form of
ADAM-9 did not show these effects. Furthermore, rescue
of ADAM-9 KO keratinocytes by the addition of recombinant
ADAM-9 was shown to reduce migration by 20 and 30%
after 4 and 8 hours respectively, thus attenuating the
accelerated ‘‘migration phenotype’’ observed in the KO
keratinocytes (Figure 8d).
Thus, these results indicate collagen XVII shedding as the
main molecular process altered in Adam-9 KO, which is
associated with increased keratinocyte migration.
DISCUSSION
The specific tissue functions of ADAM proteases in skin are
well understood. These molecules have different domains
that display different functions, such as membrane fusion,
cytokine and growth factor shedding, and cell adhesion and
migration (Edwards et al., 2008). The sheddase activity of
epidermal ADAMs may have an important role in keratino-
cyte biology; for instance, the shedding of heparin-binding
EGF-like growth factor and other EGFR ligands has been
shown to regulate keratinocyte proliferation and migration
(Izumi et al., 1998).
Among the ADAMs, ADAM-9, -10, and -17 are expressed
by keratinocytes in intact human epidermis. In addition,
ADAM-9 is also produced by fibroblasts (Zigrino et al., 2007).
In murine skin as well as in human skin, ADAM-9 has a
preferential localization throughout the epidermal layer
(Zigrino et al., 2007). Interestingly, we observed a significant
induction of ADAM-9 transcripts in human chronic wounds,
thus suggesting a role for this protein in pathological
skin repair. Chronic wounds with delayed, insufficient,
or missing wound closure are characterized by pathologic
inflammation, fibroblast senescence, and uncontrolled
proteolysis (Diegelmann and Evans, 2004). Excess proteolysis
may lead to destruction of wound extracellular matrix,
disturbance of cell migration, or degradation of momentous
growth factors and their receptors. However to understand
what is the function of ADAM-9 in this context, we needed
to understand which function it may have during physio-
logical wounding. To address this question, we have
analyzed the distribution of this protease in normal wound
healing.
During wound healing, expression of this protein was
observed in all migrating and proliferating layers of the
epidermis with an increased level detected in the initial
phases post-wounding (Figure 1). During these initial phases
within a few hours after injury, epidermal keratinocytes at the
wound edge detach from the underlying basement membrane
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Figure 5. Increased length of migrating epithelial tongue. (a) Epithelia migrating tongues, marked by broken line, of knockout (KO) and wild-type (WT)
wounds stained for hematoxylin/eosin. The length of the tongues was measured in four different wounds from each WT and KO animal at days 3 and 5
post-wounding with the result shown graphically. (b) Sections of 3- and 5-day-old wounds were stained with antibodies for Ki67 to examine keratinocyte
proliferation. The number of positive cells was counted from the beginning and through the tongue in four different wounds of WT and KO animals and
the results are shown on the right. Scale bar, 100 mm.
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and from adjacent cells and start to migrate into the wound,
typically underneath the scab (Martin, 1997). After 2–3 days,
wound keratinocytes distant from the wound edge also obtain
a hyperproliferative phenotype, and thus increased the cell
number and migration to fill the gap in the epithelium
(Martin, 1997).
In wound healing experiments performed with animals
with complete ADAM-9 ablation, we could observe an
accelerated wound re-epithelialization. Thus, taking together
the expression profile and the altered re-epithelialization, we
could suggest that ADAM-9 may be involved in regulating
either migration or cell proliferation necessary for re-
epithelialization. Inflammatory processes that occur in the
early phases of wound healing (Martin, 1997) seemed to be
unaffected as we could not see any differences in neutrophil
and macrophage infiltration. Furthermore, we have not
detected differences in cell proliferation in wounds from
days 1, 3, and 5, but have detected more extended epithelial
migrating tongues in days 3 and 5 wounds from KO animals
compared with WT animals. These data suggest that
accelerated re-epithelialization in ADAM-9 KO animals
may result from increased epithelial migration. Indeed, this
seems to be the case as in vitro analysis of keratinocytes
isolated from KO animals shows that these cells migrate faster
than do the littermate controls.
Few data are available on the putative function of ADAM-9
during epidermal migration in wound healing and these
come from in vitro experiments. For instance, shedding of
collagen XVII from keratinocytes by ADAMs -9, -10, and -17
has been implicated in regulating motility of the cells because
of the inhibitory effect of the shed collagen XVII ectodomain
on migration (Franzke et al., 2002, 2009). In addition,
ADAM-9 has been shown to bind a3b1-integrin on human
keratinocytes lines and induce the expression of MMP-9 and
subsequent cell migration in a manner that involves activa-
tion of ERK-mitogen-activated protein kinase (Zigrino et al.,
2007). Thus, the lack of ADAM-9 may result in altered
migration of keratinocytes because of impairments in MMP-9
expression and/or alteration of collagen XVII shedding. In
support of this, studies with MMP-9-deficient mice showed
enhanced re-epithelialization of cornea and skin, probably
because of the enhanced epithelial cell proliferation (Mohan
et al., 2002). However, we could not detect differences in
MMP-9 activity in lysates from wounds from days 1 to 5 and
also in supernatants of primary keratinocytes, but only a slight
difference in MMP-9 expression in the epithelial migrating
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Figure 6. Collagen XVII expression in Adam-9 knockout (KO) and wild-type (WT) wounds. (a) Collagen XVII was immunolocalized in wounds at days 1, 3, and
5 post-wounding using specific antibodies to the NC15 domain of the protein. White arrows indicate areas of the tip where expression of collagen XVII is
detected, and the stars at day 1, the edge of the wound. Note that in the epithelial migrating tip of WT wounds at day 5, staining for collagen XVII is almost
absent, whereas it is still present in the keratinocytes of KO tips. Scale bar, 100 mm. (b) Collagen XVII was analyzed by immunoblot in wound extracts (5 mg) from
different wounds/animals (numbered from 1 to 4) at days 1 and 5 post-wounding. The shed and full-length forms of the protein are indicated on the right.
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keratinocyte tip in KO animals day 5 post-wounding. These
results suggest that it is the MMP-9 localization more than the
alterations in secretion that contribute to the observed
wound-healing phenotype. Future experiments will be aimed
at specifically addressing this issue.
Furthermore, Leivo et al. (2000) have shown that during
re-epithelialization, collagen XVII is expressed in the
keratinocytes distal to the wound edge, but not in the leading
cells of the epithelial tip. Shedding of collagen XVII may lead
to changes in the biological activities of the molecules, by
altering their functions in ligand binding, cell attachment, or
signal transduction. It has recently been shown by in vitro re-
epithelialization assays that induced shedding of collagen
XVII results in decreased keratinocyte motility (Franzke et al.,
2002). Therefore, the shed ectodomain is likely to have a role
in cell–matrix signaling through interaction with cell surface
receptors, leading to changes in lateral migration of
keratinocytes. Indeed, we could observe a persistent expres-
sion of collagen XVII in the migrating epithelial tip at days 3
and 5 post-wounding in KO but not WT animals, thus
suggesting that the expression of this molecule is not altered
events but shedding events. In agreement with this, we could
detect shed forms in wound extracts from day 1 wounds from
WT but not KO animals (data not shown). However, we failed
to detect any further shedded form in the later time points
(data not shown). Thus, the detection in situ of the collagen
XVII we observed in day 3 wounds fromWT may be the result
of detection of shed collagen XVII, which is likely to be
further cleared in day 5 wounds where the expression is
significantly reduced. In support of this hypothesis, in vitro,
primary keratinocytes isolated from Adam-9-depleted ani-
mals showed impaired constitutive collagen XVII shedding
compared with cells isolated from WT animals. Furthermore,
transfection of murine keratinocytes from null animals with
proteolytically active ADAM-9 restored collagen XVII shed-
ding, whereas proteolytically inactivated ADAM-9 mutant
(E4A) did not.
In addition, replacement of active ADAM-9 in KO
keratinocytes partly rescued the accelerated migration of
keratinocytes in vitro. Lack of a complete rescue may derive
from the use of a soluble active protein, which we have used
to circumvent the low efficiency of transfection of primary
murine keratinocytes. Thus, expression of a membrane-
bound form of ADAM-9 might have directly docked in the
vicinity of the transmembrane substrate and more efficiently
shed it completely restoring the cell phenotype.
It is possible that increased expression of ADAM-10 and -17
in day 3 KO wounds replaces additional unknown functions of
ADAM-9 that minimize the effects of ADAM-9 ablation for
skin repair. However, even if an increase in ADAM-10
expression in KO wounds at day 3 could be detected, our
data would nevertheless suggest that ADAM-9 may be
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Figure 7. Migration of Adam-9 knockout (KO) primary keratinocytes is enhanced. Time-lapse video microscopy of primary keratinocytes isolated from wild-
type (WT) or Adam-9 KO animals seeded onto collagen type I. After wounding the monolayer, cell migration was monitored over 24 hours, and the area covered
by the cell sheet at the indicated time points was calculated. Area is denoted as mm2 and is representative of two experiments performed in sextuple.
Representative microphotographs from the migration experiment are shown. Scale bar, 100mm. *Po0.03; **Po0.003.
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primarily responsible for the initial shedding events occurring
in keratinocytes during the first phases of wound repair.
In conclusion, it is possible that increased wound repair in
ADAM-9 KO animals results from the lack of induced
collagen XVII shedding, which occurs during the activation
of the wound edge keratinocytes immediately after wounding
and, in addition, from alterations in MMP-9 localization
in vivo in migrating keratinocytes.
These results show that increased expression of ADAM-9
during wound repair results in negative regulation of re-
epithelialization. Further studies will be aimed at investigat-
ing the role of ADAM-9 in chronic ulcers to open up new
ways for therapeutic intervention.
MATERIALS AND METHODS
Antibodies
For immunodetection analysis, goat polyclonal antibodies raised
against murine ADAM-9 were purchased from R&D Systems
(Wiesbaden, Germany). Ki67 antibodies were from Dako, Hamburg,
Germany (1:100) and rabbit anti-loricrin (1:100) and rabbit anti-
keratin 14 (1:250) from Babco, Richmond, CA, and rat anti-CD68
and rat anti-neutrophils from Serotec, Du¨sseldorf, Germany (1:100).
Collagen XVII antibodies were a kind gift from Prof L. Bru¨ckner-
Tudermann (University of Freiburg, Germany). Rabbit anti-MMP-9
antibodies were from Chemicon, Hofheim, Germany (1:100). Actin
was detected using a mouse mAb (MP Biomedicals, Irvine, CA).
Purified control IgG was purchased from Dako.
Cells, cell culture, and transfection
Murine epidermal keratinocytes were isolated from newborn skin as
previously described (Sudbeck et al., 1997). Keratinocytes were
cultured on collagen-coated dishes in mixture of Ham’s F12 and
Dulbecco’s modified Eagle’s medium (FAD) medium containing
50 mM Ca2þ in the absence or presence of mitomycin C-treated 3T3
fibroblasts (4mgml1) as feeders. The FAD medium (DMEM/Ham’s
F12, 3:1; Invitrogen, Karlsruhe, Germany) contained 100Uml1
penicillin, 100mgml1 streptomycin, 10% fetal calf serum, 5 mgml1
insulin, 1 ngml1 EGF, 10–10mol l1 cholera toxin, and 24 ngml1
adenine. Primary keratinocytes were seeded on collagen type I
coated (30 mgml1) 12-well plates at 8% confluency and transfected
with 2mg of DNA per well with the indicated plasmids using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
recommendations. After 5 hours, the medium was replaced and
50 mgml1 ascorbic acid was added to allow for hydroxylation of
collagen and proper triple helix formation. Fresh FAD medium
without serum supplemented with 50 mgml1 ascorbic acid was
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the active but not inactivated (E4A) human ADAM-9. ADAM-9 immunoblot confirmed expression of the proteins and actin was used as loading control.
(d) Time-lapse video microscopy of primary keratinocytes isolated from WT or Adam-9 KO animals seeded onto collagen type I. After wounding the monolayer,
KO keratinocytes were incubated in the presence of 300 ng recombinant soluble ADAM-9 and cell migration was monitored over 24 hours, and the area covered
by the cell sheet at the indicated time points was expressed as a percentage of the initial area.
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added the next day after transfection and incubated for a further
24 hours. Proteins released in the supernatants and lysates were
prepared as later described.
The plasmid encoding the soluble ADAM-9 was a kind gift from
Alex Toker (Beth Israel Deaconess Medical Center, Harvard Medical
School). The transformer site-directed mutagenesis kit (Stratagene,
Heidelberg, Germany) was used to introduce a specific mutation of
the ‘‘catalytic’’ glutamic acid in the metalloproteinase active site
(Glu - Ala; E4A) shown to result in loss of proteolytic activity of
ADAM-9 toward insulin b-chain (Roghani et al., 1999). Insertion of
mutation was confirmed by DNA sequencing.
Wound healing experiments
C57/Bl6 (8–10 weeks old) mice or C57/Bl6-SV129 Adam-9 / (KO)
and littermate controls (WT) were anesthetized with a single
intraperitoneal injection of ketamine/xylazine. These animals were
kindly provided by Prof C. Blobel (Hospital for Special Surgery,
New York) (Weskamp et al., 2002). The hair on the back was shaved
and the skin wiped with 70% ethanol. Two full-thickness excisional
wounds (4mm diameter) were created on the back of each animal
by excising the skin and panniculus carnosus as previously described
(Werner et al., 1994). The wounds were allowed to dry to form a
scab. Animals were killed at different time points after wounding and
the complete wounds, including the epithelial margins, were
isolated. Wounds were bisected in caudocranial direction and the
tissue embedded in O.C.T. Compound (Tissue Tek, Vogel, Giessen,
Germany), and used for immunohistochemistry. Histological analy-
sis was performed on serial sections from the central portion of the
wound. Cryosections (5 mm) of the wounds were stained with
hematoxylin and eosin (Shandon, Frankfurt, Germany), documented,
and measured using a Leica (DMLB, Wetzlar, Germany) microscope.
Alternatively, wounds were excised, collected in phosphate-buffered
saline (PBS) containing1% SDS, and homogenized using a Mixer
mill (3minutes, 30Hz; Retsch, Germany). Extracted proteins in
the supernatants from centrifuged extracts were transferred to new
tubes and stored at 80 1C till use. All animal experiments were
performed in compliance with the German Law for Welfare of
Laboratory Animals and approved by the Regierungspra¨sidium Ko¨ln,
Germany.
RNA isolation and reverse transcription-PCR
Total DNase-treated RNA from the skin wounds was prepared using
the RNAeasy Fibrous tissue Kit following the manufacturer’s
instructions (Qiagen, Hilden, Germany). Reverse transcription-PCR
was performed according to the manufacturer’s instructions (REDTaq
ReadyMix PCR Reaction Mix, Sigma, Taufkirchen, Germany).
Briefly, 1 mg RNA was reverse transcribed using oligodT as primer
in a total volume of 25 ml. A volume of 2ml of the cDNA was used to
amplify specific transcripts by PCR. The following primers were used
for amplification of murine ADAM-9: 50-TCTGACCATCCCAACG
TACA and 50-GCTGTTGTGCAGAGGTTCAA; murine MMP-9:
50-AGTTTGGTGTCGCGGAGCAC and 50-TACATGAGCGCTTCCGG
CAC (Kim et al., 2000); murine ADAM-10 50-GCAACATCTGGGG
ACAAACT-30, 50-TTGCATATCCCTTCCTTTGC-30; murine ADAM-12
50-ATGCCAGAACATGGACATCA-30, 50-TGGGAAGGTCTGGGTA
CTTG-30; murine ADAM-15 50-TGATGGACCCTGTTGTCAAA-30,
50-CAACAGAGGCTGGCTCCTAC-30; and murine ADAM-17 50-TT
GAGCGATTTTGGGATTTC-30, 50-CATCCTCTGGTGGTCCAGTT-30.
Amplification of murine S26 was used for normalization: 50-AATG
TGCAGCCCATTCGCTG and 50-CTTCCGTCCTTACAAAACGG
(NM013765). PCR reactions were performed on 1ml cDNA for 35
cycles (within the linear range of amplification): denaturation (94 1C,
1minute), annealing (60 1C, 1minute), and extension (72 1C,
1minute). The products were then analyzed on 2% agarose
gels in Tris/Borate/EDTA buffer.
For quantitative real-time PCR analysis, RNA was reversed
transcribed into cDNA by using random hexamers and Superscript
II Plus RNase H Reverse Transcriptase (Invitrogen, Carlsbad, CA).
The level of expression was quantified by real-time PCR using the
ABI RealTime 7300. One microliter of sample cDNA was added to
the master mix and the amplification was performed in a total
volume of 20 ml for 40 cycles. The thermal cycling conditions were
set to 50 1C for 2minutes and 95 1C for 10minutes, followed by 40
cycles of amplification at 95 1C for 15 seconds and 60 1C for 1minute
for each cycle. Primers used for the amplification were previously
described (Franzke et al., 2009).
The relative expression levels were determined by normalizing
expression to S26. Expression level of normalized samples is
displayed in relative expression units, which were calculated by
the comparative DDCt method according to the manufacturer’s
instructions.
Zymographic analysis
Equal amounts of proteins from serum-free conditioned media and
wound extracts (see above) were analyzed by gelatin zymography as
previously described (Zigrino et al., 2001). Briefly, proteins were
fractionated on 10% SDS–PAGE containing 1mgml1 gelatin
(bovine, Sigma, Deisenhofen, Germany). After electrophoresis, the
gels were washed in 2.5% Triton-X 100 for 30minutes before
overnight incubation in metalloproteinase substrate buffer (50mM
Tris-HCl, pH 8.0, 5mM CaCl2). Thereafter, the gels were stained with
Coomassie Blue R 250 and the bands corresponding to gelatinase
activities appeared white against the blue background.
Western blot analysis
Keratinocyte lysates were prepared by washing the cells twice in PBS
followed by scraping them off on ice in RIPA buffer containing the
protease inhibitors aprotinin (10 mgml1), Pefabloc (0.25mgml1),
and leupeptin (1 mgml1). After overnight incubation at 4 1C, lysates
were clarified by centrifugation at 16,000 g and 4 1C for
20minutes and the supernatant collected and stored at 20 1C till
use. Protein concentration was determined using a commercial assay
(MicroBCA, Perbio Science, Bonn, Germany). To analyze released
collagen XVII, equal amounts of supernatants were incubated
overnight with concanavalin-A-Separose (Amersham Pharmacia
Biotech, Freiburg, Germany). After centrifugation at 1,000 g for
10minutes, con-A-bound proteins were washed twice with PBS
and bound proteins eluted in sample buffer containing 0.7 M
b-mercaptoethanol. Eluted protein was further analyzed by western
blotting. Wound lysates for this analysis were prepared as described
above (‘‘zymographic analysis’’). For western blotting, proteins were
fractionated by SDS–PAGE on 7% polyacrylamide gels under
reducing conditions and transferred onto Hybond-C Super (Amer-
sham Pharmacia Biotech). After blockage of nonspecific binding
sites with 5% skimmed milk (w/v) in PBS containing 0.5% Tween
(v/v), for analysis of phosphorylated proteins 5mM sodium fluoride
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was included, and the blots were incubated with the primary
antibodies overnight at 4 1C. Bound primary antibodies were
detected using a horseradish peroxidase-conjugated secondary
antibody (1:2,000; Dako) and visualized with the ECL system
(Amersham Pharmacia Biotech).
Cell migration assays
Cell migration assays were performed in 24-well tissue culture
plates. Confluent layers of primary keratinocytes were treated with
mitomycin-C (1.6 mgml1) for two hours to arrest cell growth, then
washed, and a scratch was produced in the center of the well. After
washing twice with PBS and introducing fresh media, plates were
placed on a microscope stage heated to 32 1C in a humidified
atmosphere. For rescue experiments, keratinocytes were incubated
in the presence of 300 ng recombinant soluble ADAM-9 (R&D
Systems). Areas covered by cells at different time points were
calculated using Cell^R software (Olympus Biosystems, Munich,
Germany).
Immunolocalization
Cryosections (5mm) of wounds were fixed in methanol (20 1C) for
5minutes (neutrophils, CD68), in acetone (20 1C) for 5minutes
(keratin-14, loricrin), or in paraformaldehyde 4% for 5minutes (Florin
et al., 2006). Cryosections were then blocked with 10% BSA (Sigma)
in PBS containing 0.05% Tween and incubated with the primary
antibodies diluted in the blocking solution overnight at 4 1C. The first
antibodies are described above in the ‘‘Antibodies’’ paragraph. After
three washes each of 5minutes, bound primary antibodies were
detected using goat anti-rabbit-Alexa 594 or rabbit anti-mouse-Alexa
488 (all diluted in PBS with BSA/Tween, Invitrogen, Karlsruhe,
Germany) for 1 hour at room temperature. Nuclei were counterstained
with 1mgml1 4,6-diamidino-2-phenylindole (Roche, Mannheim,
Germany). Negative controls were performed using nonspecific IgG
as primary antibodies.
For Ki67 immunodetection, cryosections were fixed in 100%
methanol (4 1C) for 5minutes and acetone (4 1C) for 10minutes. After
rinsing with PBS, endogenous peroxidase was quenched with 3%
H2O2 in methanol for 10minutes at room temperature. The
cryosections were then blocked with 1% BSA (Sigma ) in PBS,
incubated with the primary antibodies diluted in blocking solution for
1 hour at room temperature, and followed by incubation with a
peroxidase-coupled secondary antibody plus streptavidin-peroxidase
complex and DAB staining (Vectastain ABC kit, Vector Laboratories,
Burlingame, UK). Sections were counterstained with hematoxylin.
Statistics
Two-tailed Student’s t-test was used for data analysis, with Po0.05
considered to be statistically significant.
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